Abstract
The search for whether endogenous markers of changes in glomerular filtration rate (GFR) by serum cystatin C assay and serum cystatin C compare with creatinine clearance by the Cockeroft‐Gault formula and the evaluation of its clinical significance as a marker of GFR is important in clinical practice at present. Serum cystatin C was determined by sandwich enzyme immunoassay using a kit. Control blood samples were collected from 70 healthy subjects and 168 patients with various kidney diseases. Creatinine clearance (Cockeroft‐Gault formula) as a measure of GFR, in 168 patients with various kidney diseases, depends on the creatinine clearance; GFR parameters were used to divide patients into two groups. The GFR was >80 mL/min in 38 patients (group A) and <80 mL/min in 130 patients (group B). The two groups were analyzed by correlation coefficient and diagnostic sensitivity and specificity were assessed by the receiver‐operating characteristic (ROC) plots (area under the curve). Of the 70 healthy control individuals, the serum level of cystatin C was measured as normal value range and a reference interval of 1.05±0.18 µg/mL (mean±1.96 SD, 95% confidence limits for the upper references limit is 1.4 μg/mL). In group A, serum cystatin C had no correlation to the creatinine clearance (r=0.171, P>0.05) and in group B, serum cystatin C was closely correlated to the creatinine clearance (r=−0.771, P<0.001). Diagnostic sensitivity and specificity were assessed by the ROC plots for serum cystatin C (area under the curve=0.8461, SE=0.057) and creatinine clearance (area under the curve=0.7642, SE=0.068). These data suggest that combined measurement of serum cystatin C is useful to estimate GFR, especially to detect the reduction of GFR. Further studies are required to evaluate the whether serum cystatin C as a more sensitive marker of early renal injury might be extremely useful, particularly in nonproteinuric or unapparent renal disease. J. Clin. Lab. Anal. 18:61–64, 2004. © 2004 Wiley‐Liss, Inc.
Keywords: cystatin C, creatinine clearance, glomerular filtration rate, ROC curve
REFERENCES
- 1. Meier P, Froidevaux C, Dayer E, Blanc E. Cystatin C concentration and glomerular filtration rate. Lancet 2001;357:634–635. [DOI] [PubMed] [Google Scholar]
- 2. Burkhardt H, Bojarsky G, Gretz N, Gladisch R. Creatinine clearance, Cockcroft‐Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly? Gerontology 2002;48:140–146. [DOI] [PubMed] [Google Scholar]
- 3. Xu X, Zou J, Ding X, et al. Serum cystatin C: A simple marker of glomerular filtration rate. Clin Med J China 2001;8:240–241. [Google Scholar]
- 4. Pergande M, Jung K. Sandwich enzyme immunassay of cystatin C in serum with commercially available antibodies. Clin Chem 1993;39:1885–1890. [PubMed] [Google Scholar]
- 5. Stowe H, Lawrence D, Newman DJ, et al. Analytical performance of a particle‐enhanced nephelometric immunoassay for serum cystatin C using rate analysis. Clin Chem 2001;47:1482–1485. [PubMed] [Google Scholar]
- 6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–34. [DOI] [PubMed] [Google Scholar]
- 7. Zweig MH, Campbell G. Receiver‐operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561–577. [PubMed] [Google Scholar]
- 8. Simonsen O, Grubb A, Thysll H. The blood serum concentration of cystatin C (γ‐trace) as a measure of the glomerular filtration rate. Scand J Clin Invest 1985;45:97–102. [DOI] [PubMed] [Google Scholar]
- 9. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrology 1992;38(suppl):S22–S27. [PubMed] [Google Scholar]
- 10. Risch L, Huber AR. Assessing the diagnostic accuracy of cystatin C as a marker of impaired glomerular filtration rate. Am J Kidney Dis 2002;39:661–662. [DOI] [PubMed] [Google Scholar]
- 11. Kazama JJ, Kutsuwada K, Ataka K, Maruyama H, Gejyu F. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron 2002;91:13–20. [DOI] [PubMed] [Google Scholar]
- 12. Herget‐Rosenthal S, Trabold S, Pietruck F, Holtmann M, Philipp T, Kribben A. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol 2000;20:97–102. [DOI] [PubMed] [Google Scholar]
- 13. Reed CH. Diagnostic applications of cystatin C. Br J Biomed Sci 2000;57:323–329. [PubMed] [Google Scholar]
- 14. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP. Serum cystatin C: a replacement for creatinine as a biochemical marker of GFR. Kidney Int 1994;47(suppl):S20–S21. [PubMed] [Google Scholar]
- 15. Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000;37:49–59. [DOI] [PubMed] [Google Scholar]
- 16. Bostom AG, Bausserman L, Jocques PE, et al. Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine. Arterioscler Thromb Vasc Biol 1999;19:2241–2244. [DOI] [PubMed] [Google Scholar]
- 17. Tan GD, Lewis AV, James TJ, et al. Clinical usefulness of cystatin C for the estimation of GFR in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 2002;25:2004–2009. [DOI] [PubMed] [Google Scholar]
- 18. Thervet E, Le Bricon T, Hugot V, et al. Early diagnosis of renal function recovery by cystatin C in renal allograft recipients. Transplant Proc 2000;32:2779. [DOI] [PubMed] [Google Scholar]
- 19. Tomino Y, Suzuki S, Gohdn T, et al. Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal 2001;15:25–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
